Nls Pharmaceutics Ltd (NLSP) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Nls Pharmaceutics Ltd  (NASDAQ: NLSP)

Nls Pharmaceutics Ltd Profitability Comparisons

Select each Category to receive further Information




NLSP Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q4 MRQ) - 79.45 % 68.01 % 33.05 %
Gross Margin (Q4 TTM) - 94.95 % 70.9 % 32.45 %
Gross Profit Margin 5 Yr. Avg. - 62.89 % 52.78 % 32.57 %
EBITDA Margin (Q4 MRQ) - 26.66 % 23.86 % 22.11 %
EBITDA Margin (Q4 TTM) - 30.67 % 24.92 % 19.83 %
EBITDA Margin 5 Yr. Avg. - 50.5 % 34.71 % 23.54 %
Operating Margin (Q4 MRQ) - 24.45 % 20.1 % 17.6 %
Operating Margin (Q4 TTM) - 22.7 % 18.2 % 15.49 %
Operating Margin 5 Yr. Avg. - 15.4 % 14.73 % 16.67 %
Pre-Tax Profit Margin (Q4 MRQ) - 17.23 % 13.64 % 15.34 %
Pre-Tax Profit Margin (Q4 TTM) - 20.49 % 15.11 % 11.11 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.31 % 10.65 % 12.23 %
Net Margin (Q4 MRQ) - 15.5 % 11.92 % 11.69 %
Net Margin (Q4 TTM) - 16.89 % 12.23 % 8.93 %
Net Margin 5 Yr. Avg. - 6.08 % 6.12 % 9.64 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q4 MRQ) - -0.01 % 0.35 % 0.38 %
Free Cash Flow Margin (Q4 TTM) - 19.86 % 15.34 % 8.72 %
Free Cash Flow Margin 5 Yr. Avg. - 20.91 % 15.76 % 13.83 %
Net Cash Flow Margin (Q4 MRQ) - 0 % 0.15 % 0.17 %
Net Cash Flow Margin (Q4 TTM) - 3.24 % 2.99 % 8.33 %
Net Cash Flow Margin 5 Yr. Avg. - 4.19 % 3.09 % 5.71 %
Effective Tax Rate (Q4 MRQ) - 8.19 % 12.37 % -
Effective Tax Rate (Q4 TTM)